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The S1P1 receptor, which is among the most 
highly  and  ubiquitously  expressed  members 
of the large family of G protein–coupled re-
ceptors  (Regard  et  al.,  2008),  provides  basic 
cell  functions  that  include  survival,  migra-
tion, adhesion, and proliferation (Sanchez and 
Hla,  2004; Alvarez  et  al.,  2007;  Kono  et  al.,   
2008). The receptor binds the lysophospholipid 
sphingosine-1-phosphate (S1P), triggering sig-
naling cascades coupled to the Gi pathway.
The S1P1 receptor is one of five S1P recep-
tors. Within the immune system, S1P receptor 
signaling has several roles in the regulation of 
innate and adaptive immune responses (Cyster, 
2005; Rosen and Goetzl, 2005; Goetzl et al., 
2008; Rivera et al., 2008). The S1P1 receptor 
has been shown to control lymphocyte egress 
from  the  thymus  (Matloubian  et  al.,  2004; 
Allende et al., 2008), spleen (Cinamon et al., 
2004;  Matloubian  et  al.,  2004),  and  lymph 
nodes (Matloubian et al., 2004). The impor-
tance of the S1P1 receptor in this process was 
initially recognized by the demonstration that 
immunosuppressant  compounds  that  trapped 
lymphocytes  in  lymph  nodes  and  the  thy-
mus were ligands for multiple S1P receptors 
(Brinkmann et al., 2002; Mandala et al., 2002). 
It was later shown that S1P1 receptor–deficient 
lymphocytes were not competent to exit the 
thymus  and  lymph  nodes,  demonstrating  the 
importance of the S1P1 receptor in mediating 
lymphocyte egress from these lymphoid tissues 
(Matloubian et al., 2004; Allende et al., 2008).
The lipid ligand S1P is ubiquitously syn-
thesized but largely degraded in most tissues, 
resulting in low ligand levels in lymphoid tis-
sues and higher concentrations in blood and 
lymph (Schwab et al., 2005). The S1P con-
centration differential is believed to drive lym-
phocyte egress from lymphoid tissues to blood 
and lymph via stimulation of the lymphocyte 
S1P1 receptor (Lo et al., 2005; Schwab et al., 
2005; Pappu et al., 2007).
Although the S1P1 receptor has been shown   
to provide a mandatory egress signal for lympho-
cyte emigration from the thymus, lymph nodes, 
and spleen, a similar role for the S1P1 receptor 
in  the  transfer  of  newly  formed,  immature   
B cells from the bone marrow into the periphery 
has not been described, nor is this emigration 
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S1P1 receptor expression is required for the egress of newly formed T cells from the thy-
mus and exit of mature T and B cells from secondary lymphoid organs. In this study, we 
deleted the expression of the S1P1 receptor gene (S1pr1) in developing B cells in the bone 
marrow. Although B cell maturation within the bone marrow was largely normal in the  
B cell–specific S1pr1 knockout (B-S1pr1KO) mice, their newly generated immature B cells 
appeared in the blood at abnormally low numbers as compared with control mice. In the 
bone marrow of B-S1pr1KO mice, immature B cells in contact with the vascular compart-
ment displayed increased apoptosis as compared with control mice. Forced expression of 
CD69, a negative regulator of S1P1 receptor expression, in developing bone marrow B cells 
also reduced the number of immature B cells in the blood. Attenuation of CXCR4 signaling, 
which is required for the proper retention of developing B cells in bone marrow, did not 
release immature B cells into the blood of B-S1pr1KO mice as effectively as in control 
mice. Our results indicate that the S1P1 receptor provides a signal necessary for the effi-
cient transfer of newly generated immature B cells from the bone marrow to the blood.
This article is distributed under the terms of an Attribution–Noncommercial–Share 
Alike–No Mirror Sites license for the first six months after the publication date 
(see http://www.rupress.org/terms). After six months it is available under a Cre-
ative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported 
license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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development, we analyzed the mRNA levels in sorted bone 
marrow pro–/pre– (B220+ IgM IgD), immature (B220+ 
IgM+ IgD and B220+ IgM+ IgDlow), and mature (B220+ 
IgM+  IgDhigh)  B  cell  populations  and  found  that S1pr1  
expression  was  highly  reduced  in  pro–/pre–,  immature, 
and  mature  B  cells  in  the  B-S1pr1KO  mice  compared 
with control mice (Fig. 1 A), consistent with Cre-mediated 
S1pr1 deletion occurring by the pre–B cell stage in the   
B-S1pr1KO mice. There were no compensatory increases 
of S1pr2, 3, 4, or 5 transcript levels in the B-S1pr1KO 
bone marrow B cell populations (Fig. 1, B–E).
B220+ B cells were quantified in the bone marrow, blood, 
spleen, and peripheral LNs (PLNs) of the B-S1pr1KO mice 
relative to controls (Fig. 2, A and B). Overall, total B220+ 
cell numbers in B-S1pr1KO mice were normal in the bone 
marrow and PLNs but were significantly decreased in the 
spleen and peripheral blood. In blood, spleen, and PLNs, the 
number of CD3+ T lymphocytes was unchanged (Fig. 2 B).
Numbers of immature and mature B cells are reduced  
in the blood and spleen of B-S1pr1KO mice
Analysis of the bone marrow lineage B cells in B-S1pr1KO 
mice revealed normal numbers of pro–/pre– and immature 
B cells, defined by expression of B220, IgM, and CD43, 
with a significant deficiency in the small population of ma-
ture, recirculating B cells (B220high IgM+; Fig. 3, A–D).
The peripheral blood, which normally contains imma-
ture B cells (B220+ IgMhigh IgDlow) recently released from 
the bone marrow along with recirculating mature B cells 
(B220+ IgMlow IgDhigh), was significantly deficient in both 
of  these  B  cell  populations  in  B-S1pr1KO  mice  (Fig.  3,   
E and F). Similar results were obtained with B cell matu-
ration markers CD93, CD23, and CD21 (Fig. 3, G–L). 
Immature B cell numbers in the blood of S1pr1loxP/+ mice 
were similar irrespective of the presence of the CD19-Cre 
transgene (Fig. S1), showing that Cre expression alone did 
not reduce the appearance of immature B cells in the blood.
In the spleen, the numbers of immature (B220+ IgMhigh 
IgDlow) and mature (B220+ IgMlow IgDhigh) B cells as defined 
by  surface  Ig  markers  were  both  reduced  in  B-S1pr1KO 
mice compared with controls (Fig. S2, A and B). Follicular 
B cells, which are characterized by B220+ CD21int CD23high 
expression (Fig. S2, C and D), were also found to be pres-
ent in lower numbers in the spleens of B-S1pr1KO mice 
compared with controls. Immunostained frozen sections of 
spleen tissue confirmed the reduction of B cells relative to 
T cells in the follicles of B-S1pr1KO mice compared with 
controls (Fig. S2 E). The numbers of marginal zone B cells, 
defined as B220+ CD21high CD23low, were slightly but sig-
nificantly reduced in the B-S1pr1KO mice compared with 
controls (Fig. S2 D). By histological evaluation, their ab-
sence was noted in the marginal zone regions (Fig. S2 F). 
Earlier studies using chimeras reconstituted with fetal liver 
from S1pr1-deficient embryos have shown that the S1P1 re-
ceptor on B cells was required for their proper positioning 
within the marginal zone, but did not note a decrease in 
process well understood. However, it is known that newly 
formed immature B cells transit from the bone marrow pa-
renchyma through the endothelium and into the sinusoids, 
where they are temporarily retained until their release into 
the general circulation (Osmond and Batten, 1984; Nagasawa, 
2006; Pereira et al., 2009). In this paper, we show that these 
immature B cells require the S1P1 receptor for their efficient 
appearance in the bone marrow vascular compartment and 
peripheral blood. Furthermore, the expression on bone mar-
row B cells of CD69, an S1P1 receptor–interacting protein 
that modifies thymic and lymph node egress of lymphocytes 
by lowering S1P1 receptor levels on their cell surface (Shiow 
et al., 2006), also negatively modulates the appearance of im-
mature B cells in peripheral blood. These results provide new 
details about the process of immature B cell release from the 
bone marrow by identifying the S1P1 receptor as a key regu-
lator of this process.
RESULTS
Expression of S1P receptors by bone marrow B cells
We  determined  the  expression  of  the  five  members  of 
the S1P receptor family in bone marrow B cells by real-
time quantitative PCR (RT-qPCR). Bone marrow B cells 
were sorted into four populations: (1) B220+ IgM IgD 
(pro–/pre–); (2) B220+ IgM+ IgD and (3) B220+ IgM+ 
IgDlow (immature); and (4) B220+ IgM+ IgDhigh (mature, 
recirculating) B cells. S1pr1 expression increased as differ-
entiation progressed in bone marrow B cells, showing that 
S1pr1 is regulated during the development of bone mar-
row B cells (Fig. 1 A, control). S1pr3 and S1pr4 transcripts 
were also found on developing bone marrow B cells (Fig. 1, 
C  and  D),  whereas  S1pr2  and  S1pr5  were  expressed  at 
very low levels (Fig. 1, B and E).
Generation and characterization of B cell–specific S1pr1 KO 
(B-S1pr1KO) mice
To  study  the  role  of  the  S1P1  receptor  in  B  cells,  we 
deleted the S1pr1 gene specifically in B cells using the 
Cre/loxP system. We bred mice bearing the loxP-flanked 
S1pr1 allele (Allende et al., 2003) with mice carrying the 
Cre recombinase gene under the transcriptional control 
of the endogenous CD19 promoter (Rickert et al., 1997) 
to obtain mice homozygous for the floxed S1pr1 allele 
and carrying the Cre transgene, termed B-S1pr1KO mice. 
In the CD19-Cre mice, the Cre recombinase expression 
has been detected in pre–, immature, and mature B cells 
in bone marrow and the spleen (Schwenk et al., 1997). 
To determine the magnitude and specificity of the S1pr1 
gene deletion in the B-S1pr1KO mice, we measured the 
levels of S1pr1 mRNA by RT-qPCR. Splenic B cells iso-
lated from the B-S1pr1KO mice showed a substantial re-
duction of S1pr1 mRNA expression compared with those 
from control mice, whereas mRNA levels in the thymus 
and brain were unchanged, confirming the B cell speci-
ficity of the Cre-mediated deletion (unpublished data). To 
verify the onset of S1P1 receptor deletion during B cell   JEM VOL. 207, May 10, 2010 
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released into the peripheral blood. To enumer-
ate the bone marrow parenchymal and sinusoidal   
B cells, we used in vivo antibody labeling (Galkina 
et  al.,  2005;  Reutershan  et  al.,  2005;  Pereira   
et al., 2009) that entails intravenous injection of 
PE-conjugated  anti-CD45.2  antibody  to  selec-
tively  label  hematopoietic  cells  in  the  vascu-
lar compartment. By applying this technique to   
B-S1pr1KO and control mice, we found that the 
pro–/pre–B cells were minimally labeled, as they 
were in the parenchyma, and shielded from the 
circulating antibody (Fig. 4, E–H). In contrast, 
lymphocytes in the peripheral blood were equally 
well labeled in both control and B-S1pr1KO mice 
(Fig. 4 F). A portion of each of the immature and 
mature bone marrow B cell pools was labeled by 
the injected anti-CD45.2 antibody, representing 
cells in the sinusoids. The bone marrow B cells 
that  were  not  labeled  by  injected  anti-CD45.2 
antibody  were  considered  to  be  parenchymal 
cells. We found that a significantly lower number of im-
mature B cells (B220+ IgM+ IgD and B220+ IgM+ IgDlow) 
was  labeled  by  anti-CD45.2  antibody  in  the  B-S1pr1KO 
mice compared with control mice, which is consistent with 
a defect in immature B cell egress from the bone marrow 
parenchyma  into  the  sinusoids  in  S1P1  receptor–deficient 
mice (Fig. 4 G). It might have been anticipated that an in-
ability of immature B cells to egress from the bone marrow 
into sinusoids would result in an increase in the number of   
total immature B cells in the parenchyma of the B-S1pr1KO 
mice. However, we found similar numbers of bone marrow im-
mature B cells (B220+ IgM+ IgDlow) that were CD45.2 in the 
anti-CD45.2–injected B-S1pr1KO and control mice (Fig. 4 H).
Because we did not detect an accumulation of bone 
marrow immature cells in the parenchyma of B-S1pr1KO 
mice, we considered the possibility that cells inappropriately   
retained in bone marrow because of an exit defect might 
instead undergo cell death. We used annexin V staining to   
assess the level of apoptosis in the pro–/pre– and imma-
ture B cell populations in the bone marrow of B-S1pr1KO 
mice. Although  the  annexin V+  pro–/pre–B  cell  fraction   
was similar in B-S1pr1KO and control mice, the immature   
B  cell  population  showed  significantly  higher  levels  of   
annexin V staining in B-S1pr1KO mice than in control   
mice, indicating an increased incidence of cell death (Fig. 4,   
I and J). The numbers of annexin V immature B cells in total 
bone marrow and in the parenchymal fraction were similar 
total marginal zone B cell numbers (Cinamon et al., 2004). 
In agreement with the flow cytometric data (Fig. 2), the   
B cell compartment appeared relatively normal in PLNs from 
B-S1pr1KO mice by histological analysis (Fig. S2 G).
Apoptosis is elevated in S1pr1-deficient immature B cells  
in the bone marrow
The deficiency of immature B cells in the blood and spleen 
could be explained by the inefficient release of newly formed 
B cells into the peripheral blood from their developmental 
niche in the bone marrow. To further evaluate this possibil-
ity, we labeled rapidly proliferating B cells with a pulse of 
BrdU and, after 48 h, determined the numbers of BrdU-
labeled B cells in the bone marrow and peripheral blood 
(Fig. 4, A–D). Within the bone marrow, the fraction of   
B cells labeled with BrdU was similar in the B-S1pr1KO 
and control mice, with no significant labeling differences 
observed between pro–/pre– (B220low IgM) and immature   
B  cell  populations  (B220low  IgM+;  Fig.  4,  A  and  B). 
However, the total number of BrdU+ B220+ cells in the 
blood from the B-S1pr1KO mice was significantly lower 
than in control mice, with lower numbers of BrdU+ im-
mature (B220+ IgMhigh IgDlow) and mature (B220+ IgMlow 
IgDhigh) B cells observed (Fig. 4, C and D).
Upon leaving the bone marrow parenchyma, immature 
B  cells  pass  through  an  endothelial  barrier  and  enter  the 
blood sinusoids, where they are retained before finally being 
Figure 1.  Expression of S1P receptors in bone mar-
row B cell subpopulations. (A–E) mRNA expression for 
S1pr1 (A), S1pr2 (B), S1pr3 (C), S1pr4 (D), and S1pr5 (E) in 
sorted B cell subpopulations from control and B-S1pr1KO 
bone marrow was determined by real-time PCR. Bars repre-
sent mean values ± SD from three experiments (n = 3 mice 
per genotype). **, P < 0.01 (Student’s t test).1116 Immature B cell exit requires S1P1 receptor | Allende et al.
rectly stimulate migration of immature B cells from bone 
marrow by its relatively high levels in the blood. This pos-
sibility prompted us to determine the potency of S1P as a 
chemotactic factor for bone marrow B cells from control 
and B-S1pr1KO mice in an in vitro chemotaxis assay. Of 
pro–/pre–, immature, and mature B cells from control mice, 
only immature B cells showed a dose response toward S1P. 
However, this migration response was not significantly dif-
ferent from that of bone marrow B cell populations from the 
B-S1pr1KO mice (Fig. S4). SDF-1 stimulated a migration 
response in bone marrow B cells that was similar in both 
types of mice (Fig. S4).
The S1P3 receptor has been shown to play a role in 
S1P-directed chemotaxis for splenic marginal zone B cells 
(Cinamon et al., 2004). Thus, we tested the ability of S1P3 
receptor–deficient bone marrow B cells to migrate toward   
S1P.  Interestingly,  S1pr3  KO  bone  marrow  immature   
B cells migrated significantly less well than WT cells to 
increasing S1P concentrations (Fig. 5 A). We next deter-
mined the number of immature and mature B cells in the 
blood and spleen in these KO mice to assess a potential 
bone marrow exit defect. In blood, there was a significant 
decrease  in  immature  B  cells  compared  with WT  mice 
(Fig. 5 C), but this decrease was much less profound than 
that observed in the blood of B-S1pr1KO mice (Fig. 3 F). 
Bone marrow and splenic B cells in S1pr3 KO mice did 
not show significant changes compared with WT (Fig. 5,   
B and D). These data indicate that although the S1P3 re-
ceptor is more potent than the S1P1 receptor in mediating 
an in vitro migration response of immature bone marrow   
B cells to S1P, the egress defect of immature bone mar-
row B cells was much more pronounced in B-S1pr1KO 
than in S1pr3 KO mice.
Because adhesion properties of mature B cells can be 
regulated by S1P1 receptor expression (Halin et al., 2005), 
we determined the cell-surface expression of CD49d (in-
tegrin  4;    subunit  of VLA-4),  CD49b  (integrin  2;   
 subunit of VLA-2), CD11a (integrin L;  subunit of 
LFA-1), and CD62L (L-selectin) on bone marrow B cells, 
but did not find a difference in the expression of these 
adhesion  molecules  between  B-S1pr1KO  and  control 
mice (unpublished data).
CD69 overexpression reduces the number of immature  
B cells in blood
CD69,  a  C-type  lectin,  was  up-regulated  on  the  sur-
face of pro–/pre– and immature bone marrow B cells in   
B-S1pr1KO mice compared with control mice (Fig. 6 A), 
similar to what has previously been described for thymo-
cytes and for mature T and B cells when S1pr1 was deleted 
(Matloubian et al., 2004). In thymocytes, forced overex-
pression of CD69 blocked egress of maturing T cells from 
thymus (Lauzurica et al., 2000; Feng et al., 2002; Nakayama 
et al., 2002). To determine if CD69 transgenic expression 
by developing bone marrow B cells also impedes their pe-
ripheral blood expression, we established a transgenic mouse 
in the B-S1pr1KO and control mice, showing that there was 
not a deficiency of viable, potentially egress-competent im-
mature B cells because of the deletion of the S1P1 receptor 
(Fig. S3,  A and B).
We next determined if the increased annexin V+ frac-
tion of immature B cells was in the parenchymal or si-
nusoidal  cell  pools  by  first  labeling  cells  in  the  vascular 
compartment by injection of mice with anti-CD45.2 anti-
body. There was no difference between B-S1pr1KO and 
control mice in the annexin V staining of the immature 
cells  that  were  shielded  from  the  anti-CD45.2  antibody 
(parenchymal cells; Fig. 4 K). However, there was a signifi-
cantly higher percentage of annexin V+ immature B cells 
(IgM+ IgDlow) labeled by anti-CD45.2 antibody (sinusoi-
dal cells) in B-S1pr1KO mice compared with control mice 
(Fig. 4 L). These results indicate that S1pr1-deficient im-
mature bone marrow B cells, in contact with the vascular 
compartment, undergo elevated apoptosis.
S1P1 receptor deficiency does not alter the migration  
of bone marrow B cells to S1P
S1P is a chemotactic factor for some B cell types (Cinamon 
et al., 2004; Rubtsov et al., 2005; Kabashima et al., 2006; 
Cinamon et al., 2008; Rubtsov et al., 2008) and might di-
Figure 2.  Reduced numbers of B cells in the blood and spleens of 
B-S1pr1KO mice. (A and B) Flow cytometry analysis of B220+ B cells and 
CD3+ T cells in peripheral tissues from 8–12-wk-old B-S1pr1KO and con-
trol mice. Lymphocytes from the bone marrow, peripheral blood, spleens, 
and PLNs from control and B-S1pr1KO mice were analyzed by flow  
cytometry using FITC-conjugated anti-B220 and PE-conjugated anti-CD3 
antibodies. Results are shown as histograms (A) and the absolute  
number of cells counted (B) in each organ or per microliter of peripheral 
blood. In B, bars represent mean values of pooled data, and the closed 
circles are individual mice. Data are pooled from two to four experiments. 
*, P < 0.05; ***, P < 0.005 (Student’s t test).JEM VOL. 207, May 10, 2010 
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an antibody that recognizes an intracellular epitope of the 
S1P1 receptor (Sinha et al., 2009) indicated a reduced level 
of S1P1 receptor expression on IgM+ bone marrow cells of 
the CD69 transgenic mice compared with those of con-
trol mice (Fig. 6, F and G). To confirm that CD69 over-
expression negatively regulates S1P1 receptor expression on 
the cell surface, we also examined S1P1 receptor cellular 
localization  when  it  was  coexpressed  with  human  CD69 
in HEK293 cells. When we expressed CD69 in wild-type 
HEK293 cells, CD69 was localized intracellularly in vesicles 
and on the plasma membrane (Fig. S5 B). When HEK293 
cells  stably  expressing  S1P1-GFP  (Liu  et  al.,  1999)  were 
transfected with CD69, S1P1-GFP expression decreased on 
the plasma membrane and some colocalized with CD69 in 
intracellular compartments (Fig. S5 C). These data confirm 
that S1P1 receptor expression on the plasma membrane is 
down-modulated by CD69 expression.
CXCR4 antagonism does not stimulate the release  
of developing B cells from bone marrow into the blood  
of B-S1pr1KO mice
Interaction of the chemokine receptor CXCR4 with its 
ligand SDF-1 is required for the retention of developing 
B cells in the bone marrow parenchyma (Nagasawa et al., 
line that expressed human CD69 in bone marrow B cells 
after onset of CD19-Cre expression during B cell develop-
ment (Fig. 6 B and Fig. S5 A).
Transgenic expression of CD69 had no discernible effect 
on the number of bone marrow lineage B cells (Fig. 6 C). 
However, these transgenic mice showed a decrease in the 
number of immature and mature B cells in peripheral blood 
compared with control mice (Fig. 6 D), which is similar to 
the observed phenotype for the B-S1pr1KO mice (Fig. 2) 
and consistent with a bone marrow B cell exit defect. We 
also detected significantly higher levels of annexin V stain-
ing in immature B cell populations in the bone marrow of   
the CD69 transgenic mice (Fig. 6 E), suggestive of higher 
levels of cell death in a manner similar to the S1P1 receptor–
deficient bone marrow B cells.
Previous studies have shown that CD69 forms a complex 
with the S1P1 receptor and that overexpression of CD69 can 
down-modulate the surface expression of the S1P1 receptor, 
thereby limiting its signaling activity (Shiow et al., 2006). 
We were unable to determine the S1P1 receptor expres-
sion level on the surface of B cells of the CD69 transgenic 
mice, because there is no antibody available that recognizes 
an extracellular epitope of the S1P1 receptor on mouse   
B cells (Lo et al., 2005). However, immunostaining with 
Figure 3.  Reduced numbers of mature and immature B cells in the blood of B-S1pr1KO mice. (A–D) Bone marrow B cell subpopulations from 
control and B-S1pr1KO mice were analyzed by flow cytometry using FITC-conjugated anti-B220, APC-conjugated anti-IgM, and PE-conjugated anti-
CD43 antibodies. Pro–/pre–B cells were identified as B220low IgM, immature B cells were identified as B220low IgM+, and mature B cells were identified 
as B220high IgM+. Pro–B cells were identified as B220low IgM CD43+ and pre–B cells were identified as B220low IgM CD43. Results are shown as den-
sity plots (A and C) and as the absolute number of cells counted per femur (B and D). The percentage of cells in each gate is indicated on the plots. Bars 
represent mean values of pooled data from two experiments, and the closed circles are individual mice. *, P < 0.05 (Mann-Whitney test). (E–L) B cells 
from the peripheral blood of control and B-S1pr1KO mice were analyzed by flow cytometry. Immature B cells were identified as B220+ IgDlow IgMhigh  
(E and F), B220+ CD93+ (G and H), B220+ CD23low IgMhigh (I and J), and B220+ CD21low IgMhigh (K and L). Mature B cells were identified as B220+ IgDhigh 
IgMlow (E and F), B220+ CD23high IgMlow (I and J), and B220+ CD21high IgMlow (K and L). Results are expressed as a density plot (E, G, I, and K) and the abso-
lute number of cells counted per microliter of peripheral blood (F, H, J, and L). *, P < 0.05; ***, P < 0.005 (Mann-Whitney test). Data in F, H, J, and L are 
mean values representative of three independent experiments.1118 Immature B cell exit requires S1P1 receptor | Allende et al.
an increase of these cells in the spleens in either control 
or B-S1pr1KO mice after antagonist treatment, ruling out 
that these immature B cells might be trapped in other lym-
phoid organs (unpublished data). The cell-surface expres-
sion of CXCR4 was similar on bone marrow B cells from 
control and B-S1pr1KO mice (Fig. 7 B). These results in-
dicate that the S1P1 receptor provides a necessary signal 
for B cell release from the bone marrow when CXCR4 
signaling is attenuated.
1996;   Tachibana et al., 1998; Zou et al., 1998; Ma et al., 1999; 
Nie et al., 2004; Ueda et al., 2004; Pereira et al., 2009). 
When control mice were treated with AMD3100, a po-
tent CXCR4 antagonist (Broxmeyer et al., 2005), imma-
ture bone marrow B cells (B220+ CD93+ IgM+ IgD and 
B220+  CD93+  IgM+  IgDlow)  were  released  into  periph-
eral blood (Fig. 7 A). In contrast, the release of immature 
B cells into blood was significantly lower in B-S1pr1KO 
mice after antagonist treatment (Fig. 7 A). We did not find 
Figure 4.  Immature B cells in the bone marrow do 
not efficiently enter blood and have elevated apo-
ptosis in the absence of S1P1 receptor. (A–D) Mice 
were pulsed with BrdU, and B cells from the bone mar-
row (A and B) and peripheral blood (C and D) of control 
and B-S1pr1KO mice were analyzed by flow cytometry 
using anti-B220, anti-IgD, and anti-IgM antibodies in 
combination with BrdU detection methodology, as de-
scribed in Materials and methods. Results are shown as 
dot plots (A and C), and as absolute numbers of BrdU+ 
B220low IgM (pro–/pre–) and B220low IgM+ (immature) 
B cells per femur (B) and BrdU+ B220+ IgDlow IgMhigh 
(immature) and B220+ IgDhigh IgMlow (mature) B cells per 
400 µl of blood (D). The percentage of cells in each gate 
is indicated on the plots. Bars represent mean values, 
and the closed circles are individual mice. Data are rep-
resentative of three experiments with three to five mice 
of each genotype per experiment. *, P < 0.05; **, P = 0.01 
(Student’s t test). (E and G) In vivo staining of bone mar-
row sinusoidal B cells. Mice were injected intravenously 
with PE-conjugated anti-CD45.2 antibody. After 2 min, 
the bone marrow cells and peripheral blood were ob-
tained and stained with PerCP-conjugated anti-B220, 
APC-conjugated anti-IgM, and FITC-conjugated anti-IgD 
antibodies. Results are shown as histograms (E) and as 
the percentage of CD45.2-PE+ (sinusoidal cells; G) for 
pro–/pre– (B220+ IgD IgM), immature (B220+ IgM+ 
IgD and B220+ IgM+ IgDlow), and mature (B220+ IgM+ 
IgDhigh) bone marrow B cells from control and B-
S1pr1KO mice. On the histograms (E), the bars show the 
percentage of PE-CD45.2+ cells for each group. (F) Lym-
phocytes stained in the peripheral blood by injection of 
PE-conjugated anti-CD45.2 antibody, showing equal 
staining in control and B-S1pr1KO mice. (H) Cells that 
were negative for anti-CD45.2–PE antibody staining 
were considered as parenchymal cells. Results are shown 
as mean values of four independent experiments (n = 
10–12 mice per genotype). *, P < 0.05; **, P < 0.01; ***,  
P < 0.005 (Mann-Whitney test). (I and J) Annexin V stain-
ing was determined on B cells from the bone marrow of 
control and B-S1pr1KO mice. Results are shown as den-
sity plots (I) and as the percentage (J) of annexin V+ PI 
B220low IgM (pro–/pre–) and B220low IgM+ (immature) 
B cells per femur. Pooled data are from five experiments 
(n = 9 for each genotype). ***, P < 0.005 (Mann-Whitney 
test). (K and L) Annexin V staining on sinusoidal and 
parenchymal immature B cells. Cells were labeled in vivo 
with PE-conjugated anti-CD45.2 antibody and gated as 
in E and H. Annexin V staining was determined on immature bone marrow B cells (B220+ 7-AAD IgM+ IgD and B220+ 7-AAD IgM+ IgDlow) partitioned 
into parenchymal cells (CD45.2; K) and sinusoidal cells (CD45.2+; L) from control and B-S1pr1KO mice. Pooled data are from three experiments (n = 8 
for each genotype). *, P < 0.05 (Mann-Whitney test).JEM VOL. 207, May 10, 2010 
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Unlike the effect of the KO of the S1P1 receptor on   
developing T cells, which caused a nearly complete block in   
their egress from the thymus and a severe deficiency of ma-
ture T cells in the periphery (Allende et al., 2004; Matloubian   
et al., 2004), in the present study mature B cells were pres-
ent  in  the  B-S1pr1KO  mice,  although  at  reduced  numbers   
in the spleen and at near normal numbers in lymph nodes. 
Although  this  finding  may  have  been,  in  part,  the  result   
of incomplete deletion of the S1P1 receptor by the CD19-Cre  
transgene in developing B cells, chimeras generated by trans-
plantation  of  embryonic  liver  from  S1pr1-null  embryos   
also  exhibited  reduced  numbers  of  B  cells  in  the  spleen 
and peripheral blood, and near normal numbers in lymph   
nodes (Matloubian et al., 2004).  These findings suggest that the 
S1P1 receptor requirement for bone marrow egress of B cells 
is not an absolute one, and that some S1P1 receptor–deficient 
B cells may escape the bone marrow. Secondary distortion of 
the peripheral mature B cell compartment in the B-S1pr1KO 
mice may be attributable to homeostatic mechanisms, which 
sense B cell deficiency (Cabatingan et al., 2002), and the trap-
ping of egress-incompetent S1P1 receptor–deficient B cells   
in lymph nodes and the spleen (Matloubian et al., 2004).
The precise mechanism through which the S1P1 recep-
tor controls egress from lymphoid organs has been difficult 
to  pinpoint.  Directed  lymphocyte  chemotaxis  to  higher 
concentrations of S1P in blood and lymph has been invoked 
as one possible means for the S1P1 receptor dependence   
of  egress  (Matloubian  et  al.,  2004);  however,  we  found 
that in the absence of the S1P1 receptor, bone marrow 
B cells migrated toward S1P no differently than control 
cells. Instead, we and others (Donovan et al., 2010) found 
that  the  S1P-directed  migration  response  of  immature 
DISCUSSION
B  cells  arise  from  pluripotent  hematopoietic  stem  cells 
through a series of developmental stages and selection steps 
in the bone marrow (Hardy and Hayakawa, 2001; Carsetti 
et al., 2004). Niches within the parenchymal extravascular 
spaces in the bone marrow populated by stromal cells sup-
ply factors to support the development and retention of the 
B cell precursors as they differentiate. Ultimately, the imma-
ture cells are released into the peripheral blood circulation to 
gain access to the spleen, where they reach maturity, whereas 
some immature B cells recirculate back and mature in the 
bone marrow (Cariappa et al., 2007; Lindsley et al., 2007).
In this paper, we show that S1P1 receptor expression 
on  developing  bone  marrow  B  cells  is  required  for  their 
efficient appearance in the sinusoidal blood compartment. 
Without  the  signal  generated  by  the  S1P1  receptor,  im-
mature cells appear to undergo increased apoptosis in the 
bone marrow while in contact with the vascular compart-
ment. We suggest that the increased cell death observed in 
S1P1 receptor–deficient mice may be a consequence of the 
inappropriate retention of the cells within the bone marrow. 
Developing B cells are known to be exquisitely sensitive to 
apoptosis (Griffiths et al., 1994). The immature B cells lacking 
the S1P1 receptor may be unable to completely transmigrate 
across the endothelium barrier separating the parenchymal 
and sinusoidal spaces, or else they may not be released from 
sinusoids after crossing the endothelium. In either case, in-
appropriately retained, apoptotic B cells would be in contact 
with the vascular compartment. Their apoptosis precludes a 
large accumulation of trapped immature cells or, potentially, 
their further maturation within the bone marrow (Cariappa 
et al., 2007; Lindsley et al., 2007).
Figure 5.  Migration of bone marrow B cells toward S1P is mediated by the S1P3 receptor. (A) Total bone marrow cells were added to a Transwell 
insert and allowed to respond to increasing concentrations of S1P or to 100 ng/ml SDF-1 in the lower well. Percentages of the input that were found in 
the lower well after a 3-h incubation with S1P (left axis) or with SDF-1 (right axis) were plotted for pro–/pre– (B220+ IgD IgM), immature (B220+ IgM+ 
IgD and B220+ IgM+ IgDlow), and mature (B220+ IgM+ IgDhigh) B cells. Data are presented as mean values ± SD (n = 3 for each genotype) and are repre-
sentative of three independent experiments. *, P < 0.05. (B–D) Distribution of B cells in S1pr3 KO mice. B cell subpopulations from the bone marrow (n = 7 
per genotype; B), blood (n = 10; C), and spleen (n = 10; D) from WT and S1pr3 KO mice were analyzed by flow cytometry using PE-Cy7–conjugated anti-
B220, APC-conjugated anti-IgM, and FITC-conjugated anti-IgD antibodies. Results are pooled data from three independent experiments. *, P < 0.05.1120 Immature B cell exit requires S1P1 receptor | Allende et al.
on the S1P1 receptor. These results suggest the possibility that 
an interplay between CXCR4 and S1P1 receptor signals may 
dictate bone marrow retention or release of the immature   
B cells into the blood. An interaction between CXCR4-
mediated retention and S1P1 receptor–mediated blood re-
lease signals has been proposed for the regulation of egress of   
plasma cells from the spleen (Kabashima et al., 2006). Inter-
estingly, the synthetic S1P receptor ligand FTY720 modifies   
CXCR4 signaling on CD34+ hematopoietic stem and pro-
genitor cells (HSPCs; Kimura et al., 2004; Walter et al., 2007).   
In addition, a direct interaction between the S1P1 and CXCR4   
receptor signaling pathways has been described in HSPCs 
overexpressing  the  S1P1  receptor,  which  inhibits  their   
SDF-1–CXCR4–dependent migration and homing to the   
bone marrow in vivo by causing down-modulation of CXCR4   
expression and signaling (Ryser et al., 2008). In the B-S1pr1KO   
mice examined in this study, however, we were unable to 
find that either CXCR4 expression or chemotaxis to SDF-1 
was altered in bone marrow B cells.
In this study, we showed that forced expression of CD69 
in bone marrow precursor B cells led to an increase in apop-
totic frequency of immature bone marrow B cells and de-
creased  numbers  of  immature  B  cells  in  blood,  copying 
the phenotype of the B-S1pr1KO mice. CD69 expression 
was previously shown to impair egress of maturing T cells 
from the thymus (Lauzurica et al., 2000; Feng et al., 2002; 
bone marrow B cells appeared to be largely mediated by 
the S1P3 receptor. Even so, B cell emigration out of bone 
marrow in S1pr3 KO mice was only slightly affected, based 
on the number of immature B cells in the blood, when 
compared with the B-S1pr1KO mice. These data suggest 
that  an  S1P-directed  chemotaxis  mechanism,  which  can 
be  recaptured  by  the  in  vitro  migration  assay,  may  not 
be a critical feature of B cell egress from bone marrow. 
Similarly, a recent study using in vivo imaging along with 
in vitro analysis of chemotaxis has argued that B cell egress 
from lymph nodes occurs by a mechanism that is distinct 
from  S1P-mediated  chemotaxis  (Sinha  et  al.,  2009).  In 
this study, and in the case of T cells egressing from lymph 
nodes, a multistep process that includes an obligatory S1P1 
receptor–mediated step for egress has been proposed (Pham 
et al., 2008). In the bone marrow, the S1P1 receptor on 
immature B cells may be critical for their transmigration 
through or release from the endothelium.
SDF-1 stimulates the Gi-linked G protein–coupled re-
ceptor CXCR4 on developing B cells to mediate their reten-
tion within the bone marrow parenchyma (Nie et al., 2004). 
We found that disruption of the SDF-1–CXCR4 axis by the 
antagonist AMD3100 elicited the release of B cell precursors 
from bone marrow in control mice but not in B-S1pr1KO 
mice, demonstrating that release of cells to the blood after   
attenuation of the SDF-1–CXCR4 signal is also dependent 
Figure 6.  CD69 expression in bone marrow  
B cells modulates the appearance of immature  
B cells in peripheral blood. (A) CD69 expression on 
bone marrow B cells. Results are shown as anti-CD69 
fluorescence intensity for cells from control and  
B-S1pr1KO mice compared with the isotype control. 
Representative results are from nine independent 
experiments. (B) Expression of the human CD69 
transgene on bone marrow total B cells in control 
and transgenic (CD69-Tg) mice. B220+ bone marrow 
cells were analyzed for their expression of human 
CD69 by flow cytometry. (C and D) Distribution of 
B220low IgM (pro–/pre–) and B220low IgM+ (imma-
ture) B cells in the bone marrow (C) and of B220+ 
IgDlow IgM+ (immature) and B220+ IgDhigh IgMlow (ma-
ture) B cells in the peripheral blood (D) of control and 
CD69 transgenic mice. Bars represent mean values, 
and the closed circles are individual mice. Data repre-
sent pooled results from three experiments. **,  
P < 0.01 (Mann-Whitney test). (E) Annexin V staining 
on B cells from the bone marrow of control and CD69 
transgenic mice. Results are shown as the percentage 
of annexin V+ PI B220low IgM (pro–/pre–) and  
annexin V+ PI B220low IgM+ (immature) B cells per 
femur and represent pooled data from four indepen-
dent experiments (n = 8). *, P < 0.05 (Mann-Whitney 
test). (F–I) Expression of S1P1 receptor on IgM+ bone 
marrow B cells of control and transgenic CD69  
mice. IgM+ cells were magnetically sorted from total 
bone marrow cells, fixed, permeabilized, and stained 
in suspension using a rabbit anti-S1P1 receptor antibody. After incubation with Alexa Fluor 488–conjugated anti–rabbit IgG, the cells were attached to a 
slide using a cytocentrifuge and visualized by fluorescence microscopy. Bar, 50 µm.JEM VOL. 207, May 10, 2010 
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delete the S1P1 receptor from B cells, S1pr1loxP/loxP mice were bred with a 
CD19-driven Cre transgenic mouse strain (CD19-Cre; Rickert et al., 1997). 
S1pr1loxP/loxP mice carrying one allele of the CD19-Cre gene (B-S1pr1KO) 
and littermate S1pr1loxP/loxP mice (used as controls) were genotyped by PCR 
using Cre-specific primers (cre1, 5-GCCTGCATTACCGGTCGATGC-3;   
cre2,  5-CAGGGTGTTATAAGCAATCCC-3).  For  some  experiments, 
S1pr1loxP/+ mice were used as controls.
B cell–specific CD69 transgenic mice. The human CD69 cDNA was 
subcloned downstream of the CAG promoter sequence from the pDRIVE-
CAG  plasmid  (InvivoGen).  A  cassette  containing  a  loxP-STOP-loxP   
fragment  from  pBS302  (Invitrogen)  was  inserted  between  the  CD69 
coding region and the promoter. A linear DNA fragment was prepared 
and  microinjected  into  the  pronucleus  of  embryos.  Potential  trans-
genic  mice  were  screened  for  the  presence  of  the  human  CD69  trans-
gene  by  PCR  analysis  of  DNA  from  tail  biopsies  (forward  primer, 
5-GTGGACAAGAAAATGATGCCA-3; reverse primer, 5-TGTAA-
CGTTGAACCAGTTGTTAAA-3) and were bred with mice carrying   
one allele of the CD19-Cre gene. Offspring that were positive for the   
human  CD69  and  Cre  transgenes  were  tested  for  the  expression  of   
the human CD69 protein on B cells by flow cytometry using an FITC-
conjugated anti–human CD69 antibody (BD). Mice lacking the Cre or the 
CD69 transgene were used as controls.
S1pr3 KO mice. S1pr3 KO mice were described previously (Kono et al., 
2004) and have been backcrossed seven times to C57BL/6 mice.
All animal procedures were approved by the National Institute of Diabe-
tes and Digestives and Kidney Diseases Animal Care and Use Committee and 
were performed in accordance with National Institutes of Heath guidelines.
BrdU labeling
For BrdU labeling, mice were injected intraperitoneally once with 200 µl of 
a 10-mg/ml BrdU solution (BD) and analyzed 48 h later. BrdU+ cells were 
detected using the FITC-BrdU Flow kit (BD) by flow cytometry.
AMD3100 treatment
B-S1pr1KO mice and littermate controls were injected subcutaneously with 
100 µl AMD3100 in PBS (5 mg/kg of body weight; Sigma-Aldrich) or PBS 
alone. After 90 min, cells from the bone marrow, blood, and spleen were 
obtained and analyzed by flow cytometry.
Detection of bone marrow sinusoidal and parenchymal B cells
To detect bone marrow sinusoidal and parenchymal B cells, we used an in 
vivo labeling procedure (Galkina et al., 2005; Reutershan et al., 2005) de-
scribed by Pereira et al. (2009). B-S1pr1KO mice and littermate controls 
were injected intravenously with 1 µg of PE-conjugated anti-CD45.2 anti-
body (clone 104; eBioscience) in 100 µl PBS. After 2 min, the mice were 
euthanized and the cells were collected from bone marrow and peripheral 
blood, and then analyzed by flow cytometry.
Lymphocyte preparation
Lymphocytes from the bone marrow, spleen, and PLNs (lingual, axillary, 
brachial, and inguinal) from mice were dissected and mechanically disag-
gregated. Single-cell suspensions were obtained using a 40-µm cell strainer. 
Peripheral blood was obtained by cardiac puncture. Red blood cells were 
removed from blood samples and splenic single-cell suspensions by NH4Cl 
lysis. In some experiments, B cells were isolated from the spleen and bone 
marrow using anti-B220 magnetic microbeads (Miltenyi Biotec) for RNA 
analysis. Absolute lymphocyte counts were determined by flow cytometry 
using counting beads (CALTAG; Invitrogen).
Flow cytometry and cell sorting
Cells were diluted in 1% BSA-PBS and incubated with anti-FcR anti-
body (BD) to block binding of conjugated antibodies to FcR. Anti–mouse 
B220  (FITC  and  PerCP  conjugated),  anti-IgM  (allophycocyanin  [APC] 
Nakayama et al., 2002), and B and T cells from lymph nodes 
(Shiow et al., 2006), by lowering the surface expression of 
S1P1 receptor through protein–protein complex formation 
(Shiow et al., 2006). We found that CD69 overexpres-
sion decreased S1P1 receptor expression in bone marrow 
B cells of the CD69 transgenic mice, and that CD69 and 
S1P1 receptor colocalized in intracellular compartments of 
HEK293 cells. The cellular trafficking pathways involved 
in the regulation of the S1P1 receptor by CD69 have not 
yet been determined.
The S1P1 receptor requirement for bone marrow exit 
extends to other cell types. Osteoclast precursors, which 
differentiate from the myeloid lineage in the bone marrow, 
rely on the S1P1 receptor to move from the bone surface 
into the peripheral blood (Ishii et al., 2009). An S1P1 re-
ceptor requirement has also been suggested for the regu-
lation of HSPC bone marrow retention and release, and 
their egress from peripheral tissues (Massberg et al., 2007). 
It will be of interest, and of potential clinical importance, 
to determine if a dependence on S1P1 receptor signaling 
extends  to  other  bone  marrow  cell  populations  for  the 
control of their emergence in blood as they traffic to pe-
ripheral tissues.
MATERIALS AND METHODS
Mice
B-S1pr1KO mice. We previously generated the S1pr1loxP/loxP mice (Allende 
et al., 2003; Allende et al., 2004) carrying the S1pr1 gene with loxP sequences 
flanking exon 2, which contains the entire coding region. To specifically 
Figure 7.  Impaired release of immature bone marrow B cells by 
CXCR4 antagonism in the absence of S1P1 receptor. (A) Mice were 
injected with the CXCR4 antagonist AMD3100 or vehicle alone, and bone 
marrow and blood were collected after 90 min. Immature bone marrow  
B cells in the blood (B220+ CD93+) were gated as IgM+ IgD and IgM+ IgDlow, 
and quantified from control and B-S1pr1KO mice. Results are shown as 
absolute numbers in 250 µl of blood. Bars represent mean values, and the 
closed circles are individual mice. Data are representative of three experi-
ments. *, P < 0.05 (Mann-Whitney test). (B) CXCR4 expression on pro–/
pre– (B220low IgM) and immature (B220low IgM+) bone marrow B cells.1122 Immature B cell exit requires S1P1 receptor | Allende et al.
System (ABI Prism 7700; Applied Biosystems). GAPDH mRNA level was 
used as an internal control.
Confocal microscopy
HEK293  cells  stably  expressing  human  S1pr1-GFP  (Liu  et  al.,  1999) 
were  obtained  from  T.  Hla  (University  of  Connecticut  Health  Center, 
Farmington, CT). A plasmid containing human CD69 driven by a CMV 
promoter was obtained from Origene.
Transient transfections were performed using the TransIT-293 reagent 
(Mirus Bio) according to the manufacturer’s instructions. Transfected cells 
were assayed 16–24 h after transfection. For immunofluorescence staining, 
cells were fixed with methanol for 5 min at room temperature and washed 
with PBS containing 0.1% Triton X-100. The cells were then incubated with 
mouse anti–human CD69 (AbD Serotec) antibody followed by Alexa Fluor 
594–conjugated goat anti–mouse IgG (Invitrogen) as secondary antibody.
Confocal laser scanning microscopy analysis was performed with a Duo-
Scan system (LSM 5 LIVE; Carl Zeiss, Inc.) using a 63 × 1.4 NA oil immer-
sion objective. Excitation and filters were as follows: GFP, laser 489-nm line 
for excitation and emission collected with LP 495-nm filter; Alexa Fluor 
594, laser 561-nm line for excitation and emission collected with LP 580-nm 
filter. Images were acquired using ZEN 2007 software (Carl Zeiss, Inc.).
Statistical analysis
Statistical significance was determined using the Mann-Whitney or Student’s 
t test. In all cases, P < 0.05 was considered statistically significant.
Online supplemental material
Fig. S1 shows that CD19-Cre expression alone does not affect the num-
bers of immature and mature B cells in blood. Fig. S2 compares the num-
bers of mature and immature B cells in spleens of control and B-S1pr1KO 
mice. Fig. S3 shows the number of viable bone marrow B cell popula-
tions in B-S1pr1KO mice. Fig. S4 examines the migration of bone mar-
row B cells of control and B-S1pr1KO mice toward S1P. Fig. S5 illustrates 
that CD69 down-regulates S1P1 receptor surface expression in HEK293 
cells.  Online  supplemental  material  is  available  at  http://www.jem.org/ 
cgi/content/full/jem.20092210/DC1.
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